Incidental US finding of a large hepatic nodule in the
right lobe.
Discussion
Focal Nodular Hyperplasia: after the early contrast
enhancement of the whole lesion, two zones can be
recognized: a central zone ("scar") in which the
enhancement has a longer duration, and a peripheral
zone, whose MR signal behaviour closely resembles
that of the normal liver parenchyma (3-5). However the scar is not always visible: its detection is reported in 20-31% of patients with CT and 35-69% of patients with MRI (2,4). The typical MR signal of the scar is not always present too, probably because of different degree of edema (5). In these cases a multimodality approach is essential for the correct diagnosis (1,4).
Final Diagnosis
Focal Nodular Hyperplasia
MeSH
Focal Nodular Hyperplasia
[C06.552.270]
Benign, usually asymptomatic nodule of the liver, occurring chiefly in women. It is a firm, highly vascular mass resembling cirrhosis, usually with a stellate fibrous core containing numerous small bile ducts, and having vessels lined by Kupffer cells. (Dorland, 28th ed)
No clear abnormality can be detected at the unenhanced scan
Contrast-enhanced CT: arterial phase. A large enhancing lesion of the right hepatic lobe is visible.
Contrast-enhanced CT: portal phase. The lesion becomes isodense to the normal liver parenchyma.
Figure 2
Unenhanced MR
Unenhanced SE T1 weighted MR image (0.5 T). No clear abnormality can be detected. The presence of a nodule can only be suspected on the basis of the displacement of the portal vein
Dynamic MR sequence (0.5 T): unenhanced T1 weighted image. The presence of a nodule can be suspected at the level of the 1st hepatic segment.
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: early arterial phase. The nodule shows marked enhancement with respect to the normal liver parenchyma.
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: arterial phase. The central portion of the nodule is hyperintense to the peripheral zone.
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: portal phase. The central portion of the nodule is still slightly hyperintense with respect to the peripheral zone.
Delayed SE T1 weighted image after contrast administration (0.5 T): the lesion is again isointense to the normal liver parenchyma
Figure 1
CT study
Figure 1a
No clear abnormality can be detected at the unenhanced scan
Figure 1b
Contrast-enhanced CT: arterial phase. A large enhancing lesion of the right hepatic lobe is visible.
Figure 1c
Contrast-enhanced CT: portal phase. The lesion becomes isodense to the normal liver parenchyma.
Figure 2
Unenhanced MR
Unenhanced SE T1 weighted MR image (0.5 T). No clear abnormality can be detected. The presence of a nodule can only be suspected on the basis of the displacement of the portal vein
Figure 3
Dynamic MR examination
Figure 3a
Dynamic MR sequence (0.5 T): unenhanced T1 weighted image. The presence of a nodule can be suspected at the level of the 1st hepatic segment.
Figure 3b
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: early arterial phase. The nodule shows marked enhancement with respect to the normal liver parenchyma.
Figure 3c
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: arterial phase. The central portion of the nodule is hyperintense to the peripheral zone.
Figure 3d
Dynamic MR sequence (0.5 T): enhanced T1 weighted image: portal phase. The central portion of the nodule is still slightly hyperintense with respect to the peripheral zone.
Figure 3e
Delayed SE T1 weighted image after contrast administration (0.5 T): the lesion is again isointense to the normal liver parenchyma